vs
agilon health, inc.（AGL）与Progyny, Inc.（PGNY）财务数据对比。点击上方公司名可切换其他公司
agilon health, inc.的季度营收约是Progyny, Inc.的4.9倍（$1.6B vs $318.4M）。Progyny, Inc.净利率更高（3.9% vs -12.0%，领先16.0%）。Progyny, Inc.同比增速更快（6.7% vs 3.1%）。Progyny, Inc.自由现金流更多（$48.6M vs $-23.5M）。过去两年Progyny, Inc.的营收复合增速更高（7.0% vs -1.1%）
agilon health是一家美国医疗保健企业，主要与基层医疗服务提供者合作，为联邦医疗保险覆盖的老年群体提供价值导向型医疗解决方案，为医生提供行政支持、临床工具及风险管理框架，在提升诊疗效果的同时降低医疗成本，业务覆盖美国20余个州。
Progyny, Inc.是总部位于美国的领先生育与家庭构建福利服务商，主要与企业雇主合作，提供试管婴儿、生育力保存、收养协助、代孕支持等综合生育相关福利方案，覆盖多个行业的雇员群体。
AGL vs PGNY — 直观对比
营收规模更大
AGL
是对方的4.9倍
$318.4M
营收增速更快
PGNY
高出3.6%
3.1%
净利率更高
PGNY
高出16.0%
-12.0%
自由现金流更多
PGNY
多$72.1M
$-23.5M
两年增速更快
PGNY
近两年复合增速
-1.1%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $318.4M |
| 净利润 | $-188.9M | $12.5M |
| 毛利率 | — | 24.1% |
| 营业利润率 | -12.3% | 4.8% |
| 净利率 | -12.0% | 3.9% |
| 营收同比 | 3.1% | 6.7% |
| 净利润同比 | -78.5% | 18.5% |
| 每股收益（稀释后） | — | $0.14 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGLPGNY
| Q4 25 | $1.6B | $318.4M | ||
| Q3 25 | $1.4B | $313.3M | ||
| Q2 25 | $1.4B | $332.9M | ||
| Q1 25 | $1.5B | $324.0M | ||
| Q4 24 | $1.5B | $298.4M | ||
| Q3 24 | $1.5B | $286.6M | ||
| Q2 24 | $1.5B | $304.1M | ||
| Q1 24 | $1.6B | $278.1M |
净利润AGLPGNY
| Q4 25 | $-188.9M | $12.5M | ||
| Q3 25 | $-110.2M | $13.9M | ||
| Q2 25 | $-104.4M | $17.1M | ||
| Q1 25 | $12.1M | $15.1M | ||
| Q4 24 | $-105.8M | $10.5M | ||
| Q3 24 | $-117.6M | $10.4M | ||
| Q2 24 | $-30.7M | $16.5M | ||
| Q1 24 | $-6.1M | $16.9M |
毛利率AGLPGNY
| Q4 25 | — | 24.1% | ||
| Q3 25 | — | 23.2% | ||
| Q2 25 | — | 23.7% | ||
| Q1 25 | — | 23.4% | ||
| Q4 24 | — | 21.3% | ||
| Q3 24 | — | 20.7% | ||
| Q2 24 | — | 22.5% | ||
| Q1 24 | — | 22.4% |
营业利润率AGLPGNY
| Q4 25 | -12.3% | 4.8% | ||
| Q3 25 | -9.1% | 6.9% | ||
| Q2 25 | -8.3% | 7.3% | ||
| Q1 25 | -1.4% | 7.5% | ||
| Q4 24 | -7.1% | 5.3% | ||
| Q3 24 | -9.2% | 4.3% | ||
| Q2 24 | -2.9% | 6.8% | ||
| Q1 24 | -0.4% | 6.7% |
净利率AGLPGNY
| Q4 25 | -12.0% | 3.9% | ||
| Q3 25 | -7.7% | 4.4% | ||
| Q2 25 | -7.5% | 5.1% | ||
| Q1 25 | 0.8% | 4.6% | ||
| Q4 24 | -6.9% | 3.5% | ||
| Q3 24 | -8.1% | 3.6% | ||
| Q2 24 | -2.1% | 5.4% | ||
| Q1 24 | -0.4% | 6.1% |
每股收益（稀释后）AGLPGNY
| Q4 25 | — | $0.14 | ||
| Q3 25 | — | $0.15 | ||
| Q2 25 | — | $0.19 | ||
| Q1 25 | — | $0.17 | ||
| Q4 24 | — | $0.12 | ||
| Q3 24 | — | $0.11 | ||
| Q2 24 | — | $0.17 | ||
| Q1 24 | — | $0.17 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.7M | $112.2M |
| 总债务越低越好 | $35.0M | — |
| 股东权益账面价值 | $126.7M | $516.0M |
| 总资产 | $1.3B | $742.4M |
| 负债/权益比越低杠杆越低 | 0.28× | — |
8季度趋势，按日历期对齐
现金及短期投资AGLPGNY
| Q4 25 | $173.7M | $112.2M | ||
| Q3 25 | $171.7M | $134.0M | ||
| Q2 25 | $171.4M | $132.5M | ||
| Q1 25 | $136.9M | $109.2M | ||
| Q4 24 | $188.2M | $162.3M | ||
| Q3 24 | $148.2M | $91.5M | ||
| Q2 24 | $109.5M | $95.0M | ||
| Q1 24 | $111.7M | $115.0M |
总债务AGLPGNY
| Q4 25 | $35.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AGLPGNY
| Q4 25 | $126.7M | $516.0M | ||
| Q3 25 | $306.1M | $560.0M | ||
| Q2 25 | $408.9M | $515.0M | ||
| Q1 25 | $500.3M | $467.2M | ||
| Q4 24 | $471.0M | $422.1M | ||
| Q3 24 | $574.9M | $434.9M | ||
| Q2 24 | $676.6M | $456.2M | ||
| Q1 24 | $689.3M | $571.6M |
总资产AGLPGNY
| Q4 25 | $1.3B | $742.4M | ||
| Q3 25 | $1.6B | $795.2M | ||
| Q2 25 | $1.7B | $761.0M | ||
| Q1 25 | $1.9B | $730.3M | ||
| Q4 24 | $1.7B | $607.1M | ||
| Q3 24 | $2.1B | $660.0M | ||
| Q2 24 | $2.2B | $698.6M | ||
| Q1 24 | $2.3B | $794.3M |
负债/权益比AGLPGNY
| Q4 25 | 0.28× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | $54.2M |
| 自由现金流经营现金流 - 资本支出 | $-23.5M | $48.6M |
| 自由现金流率自由现金流/营收 | -1.5% | 15.3% |
| 资本支出强度资本支出/营收 | 0.2% | 1.8% |
| 现金转化率经营现金流/净利润 | — | 4.34× |
| 过去12个月自由现金流最近4个季度 | $-119.0M | $191.8M |
8季度趋势，按日历期对齐
经营现金流AGLPGNY
| Q4 25 | $-20.5M | $54.2M | ||
| Q3 25 | $-18.2M | $50.7M | ||
| Q2 25 | $-35.1M | $55.5M | ||
| Q1 25 | $-32.0M | $49.8M | ||
| Q4 24 | $16.4M | $52.2M | ||
| Q3 24 | $-7.7M | $44.5M | ||
| Q2 24 | $-18.7M | $56.7M | ||
| Q1 24 | $-47.8M | $25.7M |
自由现金流AGLPGNY
| Q4 25 | $-23.5M | $48.6M | ||
| Q3 25 | $-21.3M | $46.0M | ||
| Q2 25 | $-38.3M | $50.2M | ||
| Q1 25 | $-35.8M | $47.0M | ||
| Q4 24 | $13.2M | $50.3M | ||
| Q3 24 | $-11.2M | $42.7M | ||
| Q2 24 | $-22.0M | $55.8M | ||
| Q1 24 | $-50.9M | $24.9M |
自由现金流率AGLPGNY
| Q4 25 | -1.5% | 15.3% | ||
| Q3 25 | -1.5% | 14.7% | ||
| Q2 25 | -2.7% | 15.1% | ||
| Q1 25 | -2.3% | 14.5% | ||
| Q4 24 | 0.9% | 16.8% | ||
| Q3 24 | -0.8% | 14.9% | ||
| Q2 24 | -1.5% | 18.4% | ||
| Q1 24 | -3.2% | 8.9% |
资本支出强度AGLPGNY
| Q4 25 | 0.2% | 1.8% | ||
| Q3 25 | 0.2% | 1.5% | ||
| Q2 25 | 0.2% | 1.6% | ||
| Q1 25 | 0.3% | 0.9% | ||
| Q4 24 | 0.2% | 0.6% | ||
| Q3 24 | 0.2% | 0.6% | ||
| Q2 24 | 0.2% | 0.3% | ||
| Q1 24 | 0.2% | 0.3% |
现金转化率AGLPGNY
| Q4 25 | — | 4.34× | ||
| Q3 25 | — | 3.65× | ||
| Q2 25 | — | 3.24× | ||
| Q1 25 | -2.64× | 3.31× | ||
| Q4 24 | — | 4.95× | ||
| Q3 24 | — | 4.27× | ||
| Q2 24 | — | 3.44× | ||
| Q1 24 | — | 1.52× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGL
| Medical Services | $1.6B | 100% |
| Other Operating | $2.5M | 0% |
PGNY
| Fertility Benefit Services | $208.6M | 66% |
| Pharmacy Benefit Services | $109.8M | 34% |
